Harrow Health, Inc.
HROW
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of theā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$38.77
Price-0.44%
-$0.17
1Y
Price
Market Cap
$1.445b
Small
Price/Earnings 3y Avg5y Avg
430.8x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+16.2%
EBITDA Margin+1.4%
Net Profit Margin+22.9%
Free Cash Flow Margin+16.2%
EBITDA Margin+1.4%
Net Profit Margin+22.9%
Free Cash Flow MarginRevenue
$268.675m
+25.3%
1y CAGR+41.8%
3y CAGR+36.9%
5y CAGREarnings
-$14.961m
+71.5%
1y CAGR+8.9%
3y CAGR+12.1%
5y CAGREPS
-$0.40
+69.4%
1y CAGR+19.0%
3y CAGR+20.8%
5y CAGRBook Value
$28.351m
$419.543m
Assets$391.192m
Liabilities$300.668m
DebtDebt to Assets
71.7%
6.5x
Debt to EBITDAFree Cash Flow
$14.278m
+66.4%
1y CAGR-741.8%
3y CAGR-537.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company